Half, it is and will happen. Unfortunately, baby steps are par for the course. The burden of proof is overwhelmingly favorable and the data is undisputable (independently varified by scientists in Japan, Russia, China, Austalia,and of course Canada and the US. The proverbial "foot in the mouth" was when Goldseeker (hopefully under investigation right now by the SEC) said he was quoting a veterinarian saying recaf won't be used on animals until it is proven valuable in humans. WHAT???? That bodes well for us because we know that it is about to be introduced in vets all over the US, so then recaf for humans should be a done deal.
I have a question for MataHari. IN YOUR OPINION (notice this is your opinion only) do you see Oncopet leading up to a licensing agreement SOON and who are the possible partners? Would it be Pfizer, Abaxis, Inverness, Abbott, all of the above? Also, is DrMoro reluctant to give the Elisa to universities because he wants to make sure he is fully protected by patents? Why not get recaf into Russia (is there patent protection in Russia) when the largest cancer center in Europe is comfortable using recaf and must realize early detection would be a huge step in the right direction? Why no push recaf in Russia as well as China? I have my opinions and have expressed my OPINIONS, just curious about YOUR OPINIONS. You and I agree on many fronts and I respect YOUR OPINIONS.
Everyone get ready for comments and the usual spin from the peanut gallery. Good luck to all shareholders. I see no one is falling for the manipulation anymore.
